V637 QAPI area: infection control
Written V0637 on the CMS-2567 and in QCOR.
Cited on this tag? What happens after a citation · One-page sheet for the binder
The regulation
§ 494.110 (a)(2) – The program must include, but not be limited to, the following: (ix) Infection control; with respect to this component the facility must—
(A) Analyze and document the incidence of infection to identify trends and establish baseline information on infection incidence;
(B) Develop recommendations and action plans to minimize infection transmission, promote immunization; and
(C) Take actions to reduce future incidents.
CMS's interpretive guidance
Interpretive Guidance § 494.110(a)(2)(ix)(A), (B) and (C):
The intent of QAPI in addressing infection control is to minimize the number of patients and staff who are exposed to or acquire infectious diseases at the facility.
The facility must record and follow up on all patient infections and serious adverse events. The occurrence of these events should be recorded in a centralized logbook or other tracking mechanism and regularly reviewed, with documentation of the actions taken. Surveillance information available for review should include, but not be limited to: patients’ vaccination status (Hepatitis B, pneumococcal pneumonia, and influenza vaccines); viral Hepatitis serologies and seroconversions for HBV (and HCV and ALT, if known); bacteremia episodes; pyrogenic reactions; vascular access infections; and vascular access loss due to infection.
Surveillance information generally includes at a minimum, the date of infection onset, site of infection, full identification of infecting organism(s), and antimicrobial susceptibility results.
Responsible staff should review the results of all routine and diagnostic testing (including culture and serology) upon receipt and ensure that the medical director periodically reviews recorded episodes of bacteremia, vascular access infections, soft tissue infections, and other communicable diseases to aid in tracking, trending, and prompt identification of potential environmental/staff practices issues or infection outbreaks among patients. It is important to identify the method of transmission whenever possible as well as the immune status of affected and at risk patients. Appropriate State or local public health officials should be notified of viral Hepatitis seroconversions and other infectious diseases, and clusters of adverse events that occur among patients in the facility.
The analysis of patient infection incidence during the periodic QAPI meetings may not be sufficiently timely for identification of an outbreak of infections. Tracking of infections and serious adverse events must be done on an ongoing basis to ensure the safety of the patients.
Actions taken by the facility must be appropriate to the degree of risk to patients and staff. Actions could include: in-service training in infection control; implementation of different protocols for cleaning equipment between uses; and audits of practice regarding infection control precautions for dialysis settings.
Information in this area may be recorded separately or incorporated into the QAPI documents; either method is acceptable, as long as review and analysis of the information collected is apparent.
As infection control indicators are developed, refer to the Measures Assessment Tool (MAT) for a list of the current standards of practice.
Connected tags
Tags whose guidance points here
https://middlemolecule.com/rulebook/tags/v637/